Stifel Nicolaus Cuts Xylem (NYSE:XYL) Price Target to $159.00

Key Points

• Stifel Nicolaus cut Xylem's price target from $163 to $159 while keeping a "buy" rating, implying about a 36.39% upside from the prior close.
• Xylem beat Q1 estimates with $1.12 EPS on $2.13B revenue, raised its revenue outlook (FY26 revenue $9.2–$9.3B) and set FY26 EPS guidance at $5.35–$5.60, leaving analysts with a "Moderate Buy" consensus and an average price target near $153.31.
• The board approved a $1.5 billion share repurchase program (roughly 4.8% of shares) and institutional investors hold about 88% of the stock, indicating management confidence and strong institutional interest.

Xylem (NYSE:XYL - Get Free Report) had its target price lowered by equities researchers at Stifel Nicolaus from $163.00 to $159.00 in a research note issued on Wednesday, MarketBeat.com reports. The brokerage currently has a "buy" rating on the industrial products company's stock. Stifel Nicolaus' price objective indicates a potential upside of 36.39% from the company's previous close.

Other analysts have also issued reports about the stock. Mizuho set a $138.00 price objective on shares of Xylem in a report on Wednesday, February 11th. Barclays set a $154.00 price target on Xylem in a research report on Wednesday. TD Cowen reiterated a "hold" rating on shares of Xylem in a report on Monday, February 23rd. The Goldman Sachs Group set a $158.00 target price on shares of Xylem in a report on Wednesday, February 11th. Finally, Royal Bank Of Canada dropped their price objective on shares of Xylem from $176.00 to $162.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 11th. Eight analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $153.31.

Xylem Trading Down 1.1%

Xylem stock traded down $1.33 during mid-day trading on Wednesday, reaching $116.58. 127,679 shares of the company traded hands, compared to its average volume of 2,010,806. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.62 and a quick ratio of 1.28. Xylem has a 52-week low of $116.05 and a 52-week high of $154.27. The firm has a market capitalization of $28.35 billion, a price-to-earnings ratio of 29.71, a P/E/G ratio of 1.77 and a beta of 1.18. The firm's 50 day moving average price is $123.79 and its 200 day moving average price is $135.12.

Xylem (NYSE:XYL - Get Free Report) last posted its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.09 by $0.03. Xylem had a net margin of 10.59% and a return on equity of 11.11%. The firm had revenue of $2.13 billion during the quarter, compared to analysts' expectations of $2.11 billion. During the same period last year, the company posted $1.03 EPS. The company's quarterly revenue was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, analysts anticipate that Xylem will post 5.46 earnings per share for the current fiscal year.

Xylem announced that its board has approved a share repurchase program on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its stock is undervalued.

Institutional Trading of Xylem

A number of hedge funds have recently bought and sold shares of XYL. AQR Capital Management LLC lifted its stake in shares of Xylem by 14.4% in the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company's stock worth $3,645,000 after purchasing an additional 3,900 shares during the period. NewEdge Advisors LLC increased its stake in shares of Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company's stock worth $496,000 after purchasing an additional 132 shares in the last quarter. Empowered Funds LLC lifted its position in Xylem by 56.1% during the first quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company's stock valued at $1,037,000 after purchasing an additional 3,120 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its holdings in Xylem by 97.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company's stock valued at $1,442,000 after purchasing an additional 5,509 shares during the period. Finally, EverSource Wealth Advisors LLC increased its position in Xylem by 114.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company's stock worth $154,000 after buying an additional 635 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.

Trending Headlines about Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Q1 beat on EPS and revenue; strong demand in water-treatment and metering helped results and lifted full-year revenue guidance to $9.2B–$9.3B, supporting upside to top-line growth. Xylem Reports First Quarter Results
• Positive Sentiment: Adjusted EPS of $1.12 beat consensus (~$1.09), and management raised the revenue outlook — a sign of execution that analysts cited when reiterating Buy ratings. Xylem (XYL) Q1 Earnings and Revenues Beat Estimates
• Positive Sentiment: Analysts (e.g., William Blair) maintained bullish ratings after the beat and cited strong water-metering momentum and a raised revenue outlook as reasons to stay constructive. Analyst Reiterates Buy on Xylem After Q1 Beat, Raised Revenue Outlook, and Strong Water Metering Momentum
• Neutral Sentiment: Company delivered $2.1B revenue (up ~3% reported, flat organically) and $2.2B orders (reported +3%, organic flat) — revenue growth and orders are stable but organic flatness limits upside signal. Xylem Reports First Quarter Results
• Neutral Sentiment: FY26 EPS guidance was reiterated at $5.35–$5.60 (near but slightly below some street estimates), leaving EPS upside limited even as revenue guidance was lifted. Xylem outlines $9.2B-$9.3B 2026 revenue outlook while keeping EPS at $5.35-$5.60
• Negative Sentiment: Management flagged a drag from China and a cautious tone on the call, which raised investor concerns about regional demand and growth sustainability. Xylem Inc. Balances Margin Gains With China Drag
• Negative Sentiment: After an initial pop on the earnings beat, the stock pulled back as investors focused on mixed order trends, China weakness, and the lack of EPS upside — explaining intraday selling pressure. Xylem Stock Pops Then Drops After Earnings Beat. The Water Tech Company’s Orders Are Key.

Xylem Company Profile

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.